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Abstract
Depression is among the common mental illnesses in the United States affecting 1 in 10
Americans. The U.S. Preventive Services Task Force recommended screening for
depression irrespective of the risk factors. Yet, providers struggle to implement
depression screening. Inadequate use of Patient Health Questionnaire-9 (PHQ-9)
screening tool to identify and manage depression can lead to poor patient outcomes.
PHQ-9 is valid and reliable tool used to diagnose depression and monitor treatment
response. The purpose of this project was to develop, deliver, and evaluate an educational
program for providers on the use of the PHQ-9 screening tool for the identification of
depression. The design and implementation of this educational module was guided by the
Iowa model of evidence-based practice. The research question focused on educating
providers managing depression in an outpatient psychiatric clinic about using the PHQ-9
tool and assessing their knowledge and confidence levels before education, immediately
after education intervention, and 1 month after. Six providers participated in the
educational program and completed the pretest and posttest to evaluate the education.
The results confirmed a significant change in the mean scores for participants’ knowledge
and confidence levels postintervention.. Enhancing provider’s knowledge and confidence
levels can facilitate proper diagnosis and treatment for depression, promote the health of
clients’ families, and prevent health-related complications associated with depression,
which can positively impact social change.
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Section 1: Introduction
Introduction
Depression is among the common mental illnesses in the United States. It affects
one in 10 Americans at some stage of their lives (National Institute of Mental Health
[NIMH], 2018). According to the National Survey on Drug Use and Health, more than 16
million adults in the United States (6.7%) have experienced at least one major depressive
episode, and that number includes only cases of depression that are known (Ahrnsbrak,
Bose, Hedden, Lipari, & Park-Lee, 2016). Researchers suggest that depression may be
even more common; in fact, only an estimated one out of every five individuals who
experience a major depressive disorder ever receives clinical help for depression
(Ahrnsbrak et al., 2016; Morin, 2018).
According to NIMH (2015), the number of patients diagnosed with depression
increases by about 20% each year. If depression is left untreated, it can cause disabling
symptoms that can negatively affect the quality of life. About two-thirds of suicides occur
because of depression (Ledford, 2014). According to the depression report from National
Alliance on Mental Illness (2019), women are 70% more likely to have depression
compared to men, and young adults are 60% more likely to experience depression than
adults 50 years and older. Practitioners diagnose depression when symptoms of sadness,
loneliness, irritability, worthlessness, hopelessness, agitation, and guilt are present for 2
weeks or longer, with some of these symptoms escalating to suicidal and homicidal
ideations (American Psychiatric Association [APA], 2013).
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The United States’ mental health system faces difficulties related to screening and
treating depression and other psychiatric disorders. Depression is one of the leading
causes of medical disability worldwide, costing the healthcare system over $210 billion
annually (Greenberg, Fournier, Sisitsky, Pike, & Kessler, 2015; World Health
Organization [WHO], 2014). Over 16 million adults in the United States experienced at
least one major depressive episode during 12 months in 2016 (NIMH,2017). Depression
in the United States and worldwide has both indirect and direct effects on morbidity and
mortality (Smithson & Pignone, 2017). According to WHO (2015b), moderate to severe
depression can lead to comorbidities such as heart disease, diabetes, and stroke. It can
also affect productivity at work, socialization, increased absenteeism, healthcare costs,
and suicidal tendencies.
The U.S. Preventive Services Task Force (USPSTF) recommended screening all
patients for depression irrespective of their risk factors (USPSTF, 2016). They state that
screening for depression improves the accuracy of early detection (Siu, 2016) and can
significantly improve overall health outcomes (Culpepper, Muskin, & Stahl, 2015).
According to the USPSTF guidelines, patients should be appropriately screened,
diagnosed, treated, and provided follow-up for depression. According to Gay, Kottorp,
Lerdal, & Lee (2016), failure to recognize depression can cause danger to the patient and
the community. Haefner, Daly, & Russell, (2017), listed several depression screening
tools available, such as (a) Hamilton Depression Rating Scale, (b) Zung’s Self-Rating
Depression Scale, (c) Patient Health Questionnaire-9 (PHQ-9), (d) Beck Depression
Inventory and Beck Depression Inventory-II, (e) Montgomery-Asberg Depression Rating
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Scale, (f) Cornell Scale for Depression, (g) Center for Epidemiologic Studies Depression
Scale, (h) Brief Depression Scale, and (i) Multi-Problem Screening Inventory Depression
Subscale. (Haefner et al., 2017). Of these, the PHQ-9 is the most recognized and
reputable diagnostic screening tool, which is recognized to be efficient and accurate in
the initial detection of depression (Haefner et al., 2017). The PHQ-9 has also been shown
to be a reliable and valid tool that has been described as a simple, easy-to-use ninequestion survey that helps clinicians screen and diagnose depression to make informed
decisions regarding patient treatment (Brody, Pratt, & Hughes, 2018). The PHQ-9 is the
most validated tool in mental health used by providers to diagnose depression and
monitor treatment response.
The PHQ-9 screening tool aligns with the APA’s Diagnostic and Statistical
Manual of Mental Disorders (5th ed., DSM-V) criteria for major depressive disorder,
guiding the provider to accurately diagnose and manage depression (APA, 2013). Despite
the prevalence of depression in the United States and unambiguous guidelines regarding
the use of the PHQ-9, providers continue to struggle to implement this depression
screening tool in their practice (NIMH, 2017).
The nature of this project was to educate providers on the use of the PHQ-9
depression screening tool to increase their usage, knowledge, and confidence level to
diagnose and manage depression in the outpatient clinic. The social change implications
noted were reflected in the increase the providers stated they had in both their knowledge
and confidence level, which can facilitate appropriate diagnosis and treatment, promote
the health and well-being of clients’ families, and positively impact patient outcomes.
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Problem Statement
The project took place at an outpatient clinic located in a large Southern state. The
clinic inconsistently uses the PHQ-9 tool for depression screening, which is incorporated
in the electronic medical records (EMR) for documentation when it is completed. The
DNP project was developed because of an informal meeting with the clinical team, which
included the chief psychiatrist, the office manager, and a provider. During the meeting,
the clinical staff presented the data they had collected via an anonymous form from their
quality improvement report. The clinical team indicated that not every patient with a
diagnosis of depression had been screened by providers using the PHQ-9 screening tool.
The clinical team identified the gap in practice as being a perceived lack of knowledge
and confidence level in implementing the PHQ-9 depression screening tool by providers
when they were providing care to their patients. The clinical team also reported a
persistent decline in the use of PHQ-9 screening tool by the clinic in the past 2 years.
They reported a 50% usage, which was below the national average of 60%. The
recommended standard for screening patients using PHQ-9 tool is 100% for all providers
(USPSTF, 2016).
The team also indicated that there was no formal educational module in place on
the use of PHQ-9 depression screening tool, and as a result, the providers did not fully
understand how to properly diagnose and manage depression, which led to many patients
not getting appropriate treatment or proper follow-up. The consistently low percentage of
the use of PHQ-9 by providers in managing depression convinced the clinical team there
was a need to educate. This gap in practice was addressed in this project with the goal of
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having no patient with a missed diagnosis because of lack of appropriate testing (see Siu,
2016; USPSTF, 2016). By improving the provider’s knowledge and confidence level on
the use of PHQ-9 screening tool, a positive treatment outcome was expected, as well as
achieving the public health task of early identification of depression (Porter, 2017).
The significance of this educational project is that it would increase providers’
knowledge and confidence level in the use of PHQ-9, making it easy to identify and
manage depression, which would significantly improve the patients’ overall health
outcomes (Culpepper et al., 2015). The USPSTF (2016), indicated that properly
screening for depression could be effective in improving patient treatment outcomes. The
importance of educating providers to attain competency in using depression screening
tools cannot be overstated (Abar, Hong, Aaserude, Holub, & DeRienzo, 2016). Despite
the prevalence of depression in the United States and clear-cut guidelines regarding the
use of the PHQ-9, providers continue to struggle to implement this depression screening
tool in their practice (NIMH, 2017).
The significance to the nursing profession is demonstrated by the fact that
educating providers would not only increase their clinical knowledge but also increase
their confidence level and opportunities to practice in an autonomous fashion when
treating patients with depression. It would potentially increase their patients’ positive
outcomes by promoting better health and mental well-being. Educating providers on the
use of PHQ-9 could improve the lives of their patients and prevent suicide.
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Purpose of the Project
The gap in practice was a lack of knowledge and confidence level in the providers
as it pertained to the use of the PHQ-9 screening tool. As a result, the DNP project’s
intended goal was to educate providers by implementing an educational program with an
aim to increase the usage of the PHQ-9 screening tool. A secondary goal was to improve
the providers’ confidence level in the use of this screening tool for the management of
depression. This DNP project answered the following practice-focused question:
PFQ: In providers managing depression in an outpatient psychiatric clinic, does
education on using the PHQ-9 tool increase staff knowledge and confidence level
immediately after the educational intervention and again in 1 month?
This doctoral project had the potential to address this gap in practice by
promoting better patient outcomes through early diagnosis and treatment of depression. It
will teach the providers how to administer the PHQ-9 and why it is important to use this
tool when assessing patients who appear to be depressed with the goal of appropriate
treatment and follow-up. Completion of this doctoral project should also increase nurse
providers’ confidence levels when assessing and treating those with depression. The goal
was that providers better understand the benefits of using the PHQ-9 tool.
Nature of the Doctoral Project
I obtained the sources of evidence from the following scholarly databases:
Medline, CINAHL, EBSCO host, Ovid Plus, Walden University library, Google Scholar,
and Pub Med. I performed a search related to the project topic and reviewed the current
literature. I examined a total of 750 articles. The search was limited to studies published
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in English from 2010 to 2018. The number was reduced to 60 articles with 10 selected as
relevant to the clinical setting. The final articles selected were published within 5 years of
my expected graduation date. The Iowa model guided the development of the educational
project.
A pretest was done prior to implementing the educational module to evaluate
providers’ knowledge on the use of PHQ-9 tool. The educational session was completed
using a PowerPoint educational module. A posttest was completed by participants
immediately after the educational training and another posttest was administered 1 month
after. I analyzed the results by the Statistical Product and Service Solutions (SPSS) 26.0
software. The gap in practice identified by the clinical team was the lack of knowledge
and confidence level using the PHQ-9 screening tool by providers at the clinic to
accurately diagnose and manage depression.
The purpose of the DNP project was to develop, deliver, and evaluate an
educational program for care providers regarding use of the PHQ-9 screening tool for the
identification of depression. The gap-in-practice was addressed by the creation of a staff
educational program that improved staff knowledge and confidence level on the use of
PHQ-9 screening tool for the identification of depression. This should contribute to better
patient outcomes that will include early detection of depression, appropriate treatment,
and proper follow-up as the providers understand the reasons for using the PHQ-9 tool.
Significance
The stakeholders impacted by the project included the patients, who could
potentially have better patient outcomes due to early diagnosis and treatment of
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depression. Other stakeholders included the families of the patients. Healthcare providers
who benefit from the educational sessions by acquiring increased knowledge and
confidence would also be stakeholders.
This project contributes to improving the providers’ knowledge and confidence
level on the use of PHQ-9 during patient visits, resulting in early detection of depression
and positive psychopharmacological outcomes. Early detection plays a major role in the
outcome of any health issue (Porter, 2017). Potential contributions to nursing practice
would include me being able to share the results of the project with other nurses by
presenting at conferences and by publishing. Nursing practice would also benefit by
increased knowledge about the PHQ-9 and the benefits of its use. The educational project
improved providers’ knowledge and confidence levels promoting proper use, accurate
screening, prompt identification of depression, and management of depression.
This educational project can be easily transferred to similar practice areas such as
a primary care clinic. Even though it was designed for this outpatient clinic, the
evidenced-based educational program can be used to educate providers practicing in
primary care settings to improve their knowledge and confidence level in using PHQ-9
depression screening tool to manage patients with depression.
Implications for social change would be reflected by a potential decrease in the
rate of undiagnosed depression, which can derail lives, the prevention of suicide by
depressed patients who are now being properly treated, and hopefully a more accepting
attitude of clinical depression by better understanding the prevalence of it. The PHQ-9
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screening tool could be used at other outpatient clinics that work with patients being
treated for depression.
Summary
The first section of the project paper discussed the DNP practice problem, project
purpose and question, and the significance to nursing. I also briefly discussed the
methodology and the implications for social change. The next section builds on the
foundation of the prior section, and examines the background and context of the project,
covering the literature review and theoretical framework in pursuit of developing an
educational program for providers to encourage the use of the PHQ-
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Section 2: Background and Context
Introduction
The practice problem identified at this outpatient clinic was that providers
struggled with the consistent use of the PHQ-9 screening tool to identify and manage
depression in their patients. The clinical team reported a 50% average use of the PHQ-9
screening tool by providers at the clinic, which is below the national average of 60%. The
clinic does not have any formal educational module in place on the use of PHQ-9
depression screening tool to accurately diagnose and manage depression leading to many
patients not getting appropriate treatment or proper follow-up. This DNP project
answered the practice-focused question:
PFQ: In providers managing depression in an outpatient psychiatric clinic, does
education on using the PHQ-9 tool increase staff knowledge and confidence level
immediately after the educational intervention and again in 1 month.?
The main purpose of the DNP project was to develop, deliver, and evaluate an
educational program for providers on the PHQ-9 screening tool for the identification of
depression. A secondary purpose was to improve the providers’ confidence level in the
use of this screening tool for the management of depression. For depression screenings to
be correctly and consistently performed, it becomes imperative for providers to be
appropriately educated on using the PHQ-9 depression-screening tool and gain
confidence in doing so.
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Concepts, Models, and Theories
The Iowa evidence-based practice (EBP) model was used to guide the project.
The rationale for using the Iowa model lay in the fact that it is an evaluation model that
supports a project designed to educate providers and works well with the goal of building
confidence levels. This model provides guidance to providers in everyday decisionmaking to provide quality patient care (Grove, Burns, & Gray, 2013). The Iowa model
provides opportunities for the providers to pay attention to knowledge and to question
existing nursing practices to see if they can be improved upon by using current research
findings (Buckwalter et al., 2017). The Iowa model guide was initially used at the
Federally Qualified Health Center site in Brooklyn by the clinical nursing staff in
adopting an evidence-based depression protocol, clinical guidelines for the PHQ-2 and
PHQ-9, and an EBP educational curriculum plan (Doody & Doody, 2014). The Iowa
model focuses on EBP through a structural viewpoint rather than from an individual’s
point of view, which provides guidance for decision-making to help provide quality care
(Grove et al., 2013). Using this Iowa model (see Appendix A) assists the providers to
question their existing practice and see if they can improve their knowledge and
confidence level using current research findings (Buckwalter et al., 2017).
According to Dentje (2015), the first step of the Iowa model is to identify the
problem that needs to be changed by identifying the clinical practice question, which is
triggered by a problem in the setting. If the problem is a priority, then a team is formed to
start searching for relevant literature related to the recognized problem. With insufficient
evidence, an additional literature search is necessary. The second step is to test the
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practice change (Brown, 2014). If successful, then the change can be implemented into an
organizational practice change with a continuous evaluation of the change after
implementation (Brown, 2014). Providers at the clinic manage patients with depression.
However, increasing the knowledge and confidence levels of providers regarding using
the PHQ-9 tool to manage their depression would result in a better treatment outcome.
Synthesis of the Literature
A literature search provided an overview of evidence indicating that effective
staff education modules can increase providers’ knowledge and confidence levels in
using the PHQ-9 screening tool to diagnose and manage depression in a clinical setting.
The literature review also provided a guide to developing the educational module used to
educate the provider on the use of PHQ-9 screening tool. The USPSTF (2016) suggested
that properly screening for depression could be effective in improving patient treatment
outcome, improving the accuracy of early detection, and significantly improving overall
health outcomes. The literature review by Abar et al., (2016) also emphasized that
effective treatment of depression is based on proper screening and diagnosis of patient
symptoms. Therefore, the importance of educating providers to attain competency in
using depression screening tools cannot be overstressed.
A comprehensive review of current scholarly literature on the decreased use of
and poor adherence to the PHQ-9 offered insights into the background of this problem,
the significance of the problem, evidence-based interventions to address the problem, and
evidence-based approaches to evaluate the project (Peterson et al., 2018; Terry, 2018).
Horton and Perry (2016) also conducted a study to determine the effectiveness of the
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PHQ-9 by evaluating its rating scale. The PHQ-9 was developed based on classical test
theory, the limitations of which include the fact that “data are treated as interval level, the
evaluations of scales are sample dependent, and the assumptions of CTT cannot be
formally tested” (Horton & Perry, 2016, p. 237). As a result of these limitations, Horton
and Perry introduced a new form of psychometric methodology to evaluate the PHQ-9:
the Rasch analysis. In a sample of 767 depressed patients, the researchers used the Rasch
analysis to test the outcomes of the PHQ-9 against a subjective mathematical model. The
result was a formal measurement process for screening depression using PHQ-9, the
benefit of which was to confirm the use of cut scores and clinical questions as necessary
to produce more accurate results. Horton and Perry’s examination confirmed that the
PHQ-9 is an important and reliable tool for screening depression but that it should not be
used alone if a primary care provider wants to get the best possible results. The results of
the Horton and Perry study are supported by Picardi et al. (2016), which established that
the PHQ-9 is not used for outcome evaluation only. The researchers tested the outcomes
of the PHQ-9 to determine whether its results can be improved. They were directed by
research questions that sought to determine which features of a screening program can be
improved.
The USPSTF (2016) recommend providing adequate education to providers to
increase the compliance in using the PHQ-9 screening tool. By improving providers’
knowledge and confidence levels on the use of PHQ-9 screening tool this would have a
positive treatment outcome as well as achieve the public health task of early detection of
depression, which is widely not recognized and often not getting treated. (Porter, 2017).
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The literature review uncovered evidence used to build the education program and
answer the practice-focused question. Beard, Hsu, Rifkin, Busch, and Bjorgvinsson
(2016) supported the use of the PHQ-9, explaining that it allows for a two-category
assessment of the symptoms of depression: somatic symptoms, including overeating,
poor appetite, low energy, and fatigue; and cognitive-affective symptoms, including
feeling hopeless or discouraged.
The PHQ-9 has been validated in primary care environments and used
successfully in behavioral health centers. The PHQ-9 depression tool can be selfadministered or administered by a clinician. Providers use PHQ-9 during initial visit to
assist with diagnosis and identification of problem symptoms and follow up visits to
measure treatment response and identify specific symptoms that are not responding
(APA, 2013). The PHQ-9 was developed by Kroenke, Spitzer, Williams, and Löwe
(2010) with an educational grant from Pfizer, Inc., and it is adapted from the Primary
Care Evaluation of Mental Disorders. There is no permission needed to reproduce,
translate, display, or distribute the PHQ-9 (Kroenke et al., 2010).
In several studies, the PHQ-9 scores > 10 have been shown to have a sensitivity
of 88% and a specificity of 88% for major depressive disorder (APA, 2016). A crosssectional study by Seo and Park (2015) involving 132 participants who visited the clinic
as a result of headaches resulted in the authors collecting their data from patients
suffering from migraines who were 16 years old to 70 years old in order to validate the
PHQ-9 depression screening tools. The study reported that the use of PHQ-9 tools was
reliable and valid with a sensitivity of 79.5%, and specificity of 81.7% with a positive
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predictive value of 64.6%. The study reported a negative predictive value of 90.5%. This
study concluded that the PHQ-9 is a reliable and valid tool for screening for depression in
an outpatient clinic. Several independent research studies have indicated that using the
PHQ- 9 depression-screening tool after education could promote early diagnosis and
prompt referral and management of depression (Seo & Park, 2015).
Educating providers on the use of PHQ-9 is important in today’s evolving
healthcare system may greatly improve patient treatment outcomes and overall quality of
care (DeCapua, 2018). To this effect, it is crucial for providers to receive proper
education on the use of PHQ-9 to manage depression in an outpatient clinic. My
extensive literature review guided the development of an educational module that can
effectively impact providers’ knowledge, confidence levels, and patient outcomes.
Relevance to Nursing Practice
The relevance of this educational module to nursing practice and healthcare, in
general, can be established by the prevalence of depression worldwide. In the United
States, approximately 16 million patients had experienced at least one major depressive
episode during 12 months in 2016 (NIMH, 2017). Despite the prevalence of depression in
the United States and clear-cut guidelines regarding the use of the PHQ-9, providers
continue to struggle to implement this depression screening tool in their practice (NIMH,
2017).
According to the current states of nursing practice, unidentified depression can
cause danger to the patient and their community, suggesting that patients should be
appropriately screened, diagnosed, and treated for depression (Gay et al., 2016).
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Untreated depression is a progressive mental health disorder that can result in severe
disability, frequent emergency room visits, expensive hospitalizations, suicide, and lowquality rating for the clinic. Depression has both indirect and direct effects on morbidity
and mortality (Smithson & Pignone, 2017).
The involvement of stakeholders is important to promote success in an
educational project because of the feedback they provide, which adds value to the project.
The USPSTF released a standard recommendation encouraging all providers to undergo
regular depression screening education (DeCapua, 2018). The outcome of this
educational module is meant to cause an increase in providers’ knowledge and
confidence levels in using the PHQ-9 depression screening tool in clinical settings. The
PHQ-9 is a validated screening tool, the use of which results in improved knowledge and
skills related to the best clinical practice outcomes, reduced visit times, improved staff
understanding of depression, and promotion of consistent follow-up among providers
(Thombs et al., 2014).
The involvement of the clinical team was vital to the success of this educational
project because their contribution and feedback made it valuable to the clinic providers.
Educating providers on the use of the PHQ-9 screening tool would improve their
knowledge and confidence level, which would help reduce the incidence rate of a missed
depression diagnosis in patients who visit the clinic.
Current Strategies and Practices to Address the Gap in Practice
Funderburk, Crasta, and Maisto, (2016) mentioned that the Veterans Health
Administration (VHA) successfully implemented standardized annual screening for
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depression. Being a large healthcare facility, they mandated the use of PHQ-2 and PHQ9, as the screening measures in the implementation of clinical practice guidelines for
major depressive disorders. The current strategy to address the gap in practice is
developing an educational project for providers on the use of PHQ-9 screening tool that
will increase their knowledge and confidence level. Increasing the providers knowledge
and confidence level will make it easy to identify and manage depression which would
significantly improve the patients’ overall health outcomes (Culpepper et al., 2015).
According to Seo & Park, (2015), there are different research studies suggesting that
utilizing the PHQ- 9 depression-screening tool, after educating the providers, could
promote early diagnosis and prompt referral and management of depression. By
improving provider’s knowledge and confidence level on the use of PHQ-9 screening
tool this would have a positive treatment outcome, as well as achieving public health task
of early detection of depression which is widely not recognized and not getting treated.
(Porter, 2017). Currently at the facility where the project intervention will occur, there is
no consistent usage of the PHQ-9 and providers state they do not feel confident in
administering. This project should close that gap in practice.
Advances to Nursing Practice
The gap in practice at this clinic revealed there a 50% average use of the PHQ-9
screening tool by providers at the clinic which is below the national average of 60% and
the clinic does not have any formal educational module in place on the use of PHQ-9
depression screening tool to properly diagnose and manage depression leading to many
patients not getting appropriate treatment or proper follow-up. The clinical relevance of
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this project was to educate the provider on the use of PHQ-9 screening tool, which will
improve their knowledge and confidence level to diagnosis of depression early and
provide treatment. (Hamid & MacKenzie, 2017). The USPSTF released a standard
recommendation encouraging all providers to undergo regular depression screening
education (DeCapua, 2018). Educating providers on the use of PHQ-9 is important in
today’s evolving healthcare system as it greatly improve patient treatment outcomes and
overall quality of care (DeCapua, 2018).
Local Background and Context
This staff education project was conducted in an outpatient clinic located in the
southern United States where providers struggle with the use of PHQ-9 screening tool to
identify and manage depression in their patients. The clinic has a population of
approximately 600 patients, ages 18 and older. All adult patients are eligible for
healthcare services at the clinic. The clinic has an average caseload of 120 patients per
day. It employs EMRs for documentation purposes. The staff of the outpatient clinic
consists of two psychiatrists, one office manager, two medical assistants, and six
advanced practice RNs. The clinic provides care to all ethnic’s backgrounds and
socioeconomic background. The target audience for the DNP project is the providers in
the clinic because of the lack of knowledge and confidence level in using PHQ-9
depression screening tool.
The local evidence on the relevance of the problem is that providers are not
educated properly on the use of PHQ-9 screening tool because the clinic does not have a
formal education module. There is a consistently low percentage of the use of PHQ-9 by

19
providers in managing depression convinced the clinical team there was a need to
educate. This gap in practice was addressed in this project, with the goal of having no
patient with a missed diagnosis because of lack of appropriate testing (Siu & USPSTF,
2016). At the clinic, it has been found that the impact of disability or depression affects
not only the patient, but also affects their family, friends, & the community.
The institutional context as applicable to the problem is the fact that, the clinical
team was concerned about the 50% average rate, compared to the national average of
60%, on the usage of PHQ-9 screening tool in managing depression. This justifies the
practice-focused question:
PFQ: In providers managing depression in an outpatient psychiatric clinic, does
education on using the PHQ-9 tool increase staff knowledge and confidence level
immediately after the educational intervention and again in 1 month.?
The current providers will be educated to be able to teach new providers being hired in
the clinic on the use of PHQ-9 screening tool. The increased occurrence of depression
within the U.S. population leads to a social and economic concern (CDC, 2013;
Greenberg et al., 2015). Therefore, screening local patients for depression using the PHQ9 is important because lack of proper screening for depression by providers can lead to
untreated disease, which can lead to adverse outcomes like suicide. The importance of
examining this topic is because depression is one of the leading causes of medical
disability worldwide, costing the healthcare system over $210 billion annually and, like
the local agency, the United States’ mental health system faces difficulties related to
screening and treating depression and other psychiatric disorders. (Greenberg et al., 2015;
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WHO, 2014). The impact of depression affects does not only affect the patient, but it also
affects their family, friends, & their community and is not always measurable. At the
psychiatric outpatient where the project was implemented, it was found that properly
identifying patients with depression using the PHQ-9 screening tool is important to
initiate appropriate treatment.
Role of the Doctor of Nursing Practice Student
I had no professional relationship with the proposed project site and worked
closely with the clinical team to develop the evidence based educational strategy,
implement and evaluate the program. The clinical team presented the data to the DNP
student related to the gap in practice after reviewing the EMR for patients with diagnosis
of depression to see if the providers utilized the PHQ-9 screening tool to screen for
managing their depression.
My role in this DNP project included developing, implementing and evaluating an
education module on the use of PHQ-9 depression-screening tool for six providers who
work in clinic settings that could increase their knowledge and confidence level in
managing depression. I also designed a pre/posttest questionnaire to evaluate the
providers’ knowledge on the use of PHQ-9 screening tool. The DNP student made
changes to the educational module based on feedback and then presented the program to
the six participants. The DNP student completed a pretest before the initiation of the
educational program to find out the gap in knowledge, and confidence level in using
PHQ-9 and presented the program to the six participants who are providers at the clinic.
The DNP student collected and analyzed the data and the resulting conclusions.
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My motivations for this doctoral project was to implement an educational
program that would have a difference in the lives of the mentally ill and the families and
communities in which they live. I have seen is the devastation that severe depression can
cause on a patients’ emotional health, and I desired to work with the clinical team to
implement an educational program for the providers, since they had identified a problem
from their quality report.
The only bias was the fact that the PHQ-9 screening tool was the only tool
approved by the clinic to diagnose and manage depression by providers, and the one I
was most familiar with. There was an internal bias toward the PHQ-9 when the
possibility exists that another tool may have been better accepted by the providers.
The Role of the Project Team
The clinical team collected and provided data from their quality report, which
indicated a gap in practice in this clinic. The clinical team also provided support for this
staff education module by assisting with problem identification. They presented the data
from the quality report, which they made available to this DNP learner. The clinical team
assisted with the review and analysis of the literature and identified the areas that needed
education and reviewed the pre-post-test survey. They identified the areas of needed
education based from their quality report.
Summary
This section appraised the background of the project implementation site. It
discussed the use of Iowa EBP model to guide the implementation of the project and the
relevance to nursing practice. This section also identified and defined the roles of the
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various parties involved in the project, including the role of this DNP learner. The next
Section includes a discussion of the evidence supporting the project.
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Section 3: Collection and Analysis of Evidence
Introduction
According to the USPTF, screening for depression improves the accuracy of early
detection (Siu, 2016) and improves overall health outcomes (Culpepper et al., 2015).
Despite the prevalence of depression in the United States and definite guidelines
regarding the use of the PHQ-9, providers continue to struggle to implement this
depression screening tool in their practice (NIMH, 2017).
The main problem identified was the lack of knowledge and self-confidence on
the use of PHQ-9 screening tool to diagnose and manage depression at a local facility.
The purpose of the DNP project was to develop, deliver, and evaluate an educational
intervention that addresses the management of depression using the PHQ-9 screening tool
as an instrument to identify patients suffering from depression. Screening for depression
using the PHQ-9 tool routinely by providers at the clinic provides a great opportunity to
better diagnose and manage depression. According to the statistics provided by USPFTF
(2016), approximately 16.2 million people in the United States suffer from depression
with another 35 million having experienced depression at some point in their lives. The
objective of this DNP project was to develop and implement an evidenced-based
educational module on the use of PHQ-9 tool to enhance providers’ knowledge and
confidence levels in managing depression in the outpatient clinic. The clinical team
provided the DNP student with expert opinions and recommendations in determining the
practicality, applicability, and the relevance of the staff education module in addressing
the gap in practice at the clinic. I used the Iowa EBP model to guide this project’s

24
objective; the model contributed to both the planning and implementation of the
educational module. In Section 3, I examine sources of evidence to support the project
and analysis and synthesis of the data.
Practice-Focused Question
The local problem was the perceived lack of knowledge and confidence level in
using the PHQ-9 depression screening tool by providers at an outpatient clinic when
providing care to their patients who may suffer from depression. The DNP project
answered the following practice-focused question:
PFQ: In providers managing depression in an outpatient psychiatric clinic, does
education on using the PHQ-9 tool increase staff knowledge and confidence level
immediately after an educational intervention and again in 1 month?
The purpose of this DNP project was to improve provider knowledge and confidence in
using the PHQ-9 depression screening tool. The approach aligns with the practicefocused question as it was expected that through provider education, there will be
improvement in knowledge and confidence using the PQH-9 tool.
Sources of Evidence
The sources of evidence used for the project were Medline, CINAHL, EBSCO
host, Ovid Plus, Walden University library, Google Scholar, and Pub Med. The keywords
used were depression, depression screening in outpatient clinic, types of depression
screening, depression-screening guidelines, depression screening recommendation,
evidence-based clinical practice for depression, theories, staff education training,
depression module, and validity and reliability of the PHQ-9 depression screening tool.
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The initial search yielded a total of 750 articles. Narrowing the search to articles
published in English from 2010 to 2018 reduced the number to 60 articles. Ten articles
that were relevant to the project question and the clinical setting were selected and used
for the project. These ten articles selected provided appropriate evidence to address the
practice-focused question. Studies not included in the selections were those written in
indigenous languages, those involving children younger than the age of 18 and those that
did not align with the USPSTF recommendations. The collected evidence-based
information was used to design and implement the educational module to improve
providers’ knowledge and confidence in using the PHQ-9 screening tool to help to bridge
the gap in practice and meet providers’ needs at the clinic.
Analysis and Synthesis
The review of literature and analysis answered the practice question and provided
a guide to achieve the purpose of this project. The USPSTF (2016) recommended
screening everyone for depression. Based on the data reported by the clinical team, only
50% of the patients were screened using the PHQ-9 tool, which is below the national
average of 60%. The above data from the clinic is below the USPSTF standard
requirement of 100% for all providers (USPSTF, 2016). The review and analysis of
evidence base literature supported the purpose of this educational program, which was to
increase knowledge and confidence level in providers at the clinic. Primeau, Avellaneda,
Musselman, St. Jean, and Illa (2013) supported the idea that the more providers assess
and treat depression using the PHQ-9, the more likely patients are to ultimately have
lower depression screening scores, leading to improved health outcomes and increased
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quality of life. It was also noted that the use of PHQ-9 screening tools by providers in an
outpatient clinic is vital in diagnosing and managing depression.
USPSTF (2016), indicated there is evidence suggesting that screening for
depression plays a vital role in early identifying and better treatment outcome. They also
found enough evidence supporting that there is no harm of screening for depression.
NIMH (2017) also highlighted that frequent use of the PHQ-9 tool by providers can
identify symptoms of depression early, enhance early treatment interventions, and limit
the potential for devastating complications. NIMH (2017) also indicated that many
successful suicides were carried out by patients who consulted health professionals the
week prior to their death. One important objective of this DNP project was to ensure that
providers of the facility obtained evidenced based education that can help them utilize the
PHQ-9 tool more consistently and boost their confidence level in using the tool.
Based on the literature review and analysis, USPSTF (2016) reported a negative
impact of the lack of education on the use of PHQ-9 screening tool to diagnose and
manage depression. PHQ-9 has been identified as a reliable and valid tool for screening
for depression in an outpatient clinic (Arroll, B., Goodyear-Smith, F., Crengle, S., Gunn,
J., Kerse, N., Fishman, T., . . . Hatcher, S., 2010). Several independent research studies
have indicated that using the PHQ- 9 depression-screening tool after educating the
healthcare providers promotes early diagnosis and prompt management of depression
(Seo & Park, 2015). According to Williams, Chung, & Muennig, (2017), depression is
identified as a contributing factor to increased disability globally, costing the United
States in 2016 approximately $233 billion dollars. The effect of depression to the
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economy results from increased medical care use, lower quality of life, and decreased
workplace productivity (Williams et al., 2017). NIMH (2017) also reported that more
than 16 million adults in the United States had experienced at least one major depressive
episode during 2016. Failure to recognize depression can cause danger to the patient and
the community according to USPSTF guidelines, suggesting that patients should be
appropriately screened, diagnosed, and treated for depression by providers in the clinic
(Gay et al., 2016). Despite the prevalence of depression in the United States and clear-cut
guidelines regarding the use of the PHQ-9, providers continue to struggle to implement
this depression screening tool in their practice (NIMH, 2017).
After comparing, contrasting, and synthesizing the literature, I concluded that the
use of PHQ-9 screening tools by providers in an outpatient clinic is vital in diagnosing
and managing depression. Educating providers on the use of PHQ-9 is important in
today’s evolving healthcare system as it greatly improves patient treatment outcomes and
overall quality of care (DeCapua, 2018). To this effect, it is crucial for providers to
receive proper training on the use of PHQ-9 to manage patients’ depression in an
outpatient clinic. The literature review guided the development of an educational module
that effectively and positively impacts the providers’ knowledge, confidence level, and
patient outcomes.
Participants
All six participants in the staff educational program were advanced practice RNs
providers at the clinic. The project took place in an outpatient clinic. The participants
were educated about the nature of the project. The approach for this evidence-based staff
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education project was to support the organization in the implementation and evaluation of
an educational program on the use of the PHQ-9 screening tool via provider pre- and
posttests. Participation in the educational project was voluntary. The criteria for inclusion
of the clinical team members included their specific knowledge and years of experience
in their field of practice. The clinical team for consultation for the creation of the
educational program consisted of the chief psychiatrist, the office manager, the medical
director, a nurse practitioner, and a staff nurse. All members of the clinical team had at
minimum 10 years of experience in the field of psychiatry. As the DNP project leader, I
have 6 years of experience as a family nurse practitioner and 1 year as a psychiatric nurse
but have worked in the field of psychiatry for 20 years in various roles. Participants were
not identified by name or any other specifying information for use in the educational
project. All the participants were notified and assured that all information was
confidential.
Procedure
A background analysis of the clinic’s strategy of using the PHQ-9 was completed.
A signed site agreement for permission for the project to be done in the facility was
attained. After approval from the Walden Institutional Review Board (IRB), six
participants who are advanced practice RNs participated in the project. Participation was
voluntary and each participant could withdraw from the project at any time. Gaps in the
facility’s current strategies in addressing depression were identified and used to develop
the educational training.
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The clinical team had previously collected and provided data from their quality
report indicating a gap in practice in this clinic. The current process in place for using the
PHQ-9 screening tool at the clinic was analyzed. The project clinical team and I agreed
on the content of the educational presentation. I led the development of the educational
program. The team reviewed and analyzed the literature and identified the areas that
needed education. The outline of the educational intervention was developed and
validated by the team. I was provided with expert opinions and recommendations in
determining the practicality, applicability, and the relevance of the staff education
module in addressing the practice gaps at the clinic. The Iowa EBP model was used to
guide the project’s objective and contributed significantly to both the planning and
implementation of the educational module. The outcome of the needs’ assessment was
used as a guide in developing and implementing the educational module. A 45-minute
PowerPoint educational intervention addressed the gaps identified regarding use of the
PHQ-9 depression screening tool at the clinic. Recommendations on the content of the
educational module were developed. A draft of the questionnaire reviewed for clarity,
appropriateness of the content, format, and style was competed.
The educational program consisted of a 45- minute PowerPoint presentation to
educate the participants on the use of PHQ-9 screen tool to diagnose and manage
depression in an outpatient clinic (Appendix F). The PHQ-9 tool (Appendix F) was
developed by Kroenke et al. (2010) with an educational grant from Pfizer Inc and it is
adapted from the Primary Care Evaluation of Mental Disorders. There is no permission to
reproduce, translate, display, or distribute the PHQ-9 (Kroenke et al., 2010). The PHQ-9

30
scores > 10 have been shown to have a sensitivity of 88% and a specificity of 88% for
Major Depressive Disorder. PHQ-9 screening tool was both valid and reliable in
depression screening (APA, 2016). The instruments used in this project were a 13question pre- and post-test that tested the participant’s knowledge and confidence level
on the use of depression screening tool (Appendix D). The questionnaire included three
demographic and 10 Likert-type questions. The 10 Likert-type questions were designed
to probe participants to express their perception on their knowledge and confidence of
using the PHQ-9 tool. The pre/posttest was designed as a Likert type questionnaire in
which the participants had the opportunity to quantify their perception before and after
the educational intervention. The questions were developed using a 5-point Likert type
rating scale from strongly agree = 1 to strongly disagree = 5: strongly agree (5 points),
agree (4 points), neutral (3 points), disagree (2points), and strongly disagree (1point). The
clinical team reviewed the draft of the questionnaire for clarity, appropriateness of the
content, format, and style. The nature of the project was explained to the participants
before the pretest. They were required to sign a consent to participate in the project. The
pre implementation data was collected using the pretest questionnaire. The PowerPoint
was then presented to the participants.
The six providers were required to sign a consent to participate in the project. The
nature of the project was explained to the participants before the pretest. They completed
the pretest in approximately 5-10 minutes providing a baseline for their knowledge and
confidence level in using PHQ-9 tool prior to receiving the educational program. The
PowerPoint presentation took 45 minutes and the post-implementation data was
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immediately collected after the presentation with another data point collected one month
after. All the six providers at the clinic were present at the presentation. The pre/posttest
questionnaire results remained confidential.
The anticipated outcome of this educational program was for the participants to
increase their knowledge and confidence level on the use of PHQ-9 depression screening
tool. After the intervention, the results of the pre and posttest were presented to the
clinical team. The data was analyzed using SPSS version 26 and the paired t- test was
used to determine if differences in the means were statistically significant. The results
were reported on a frequency table, descriptively and pie charts. The paired t-test was
used to calculate the p-value and the standard deviation. The anticipated outcome of this
educational program was for the participants to have increased knowledge and
confidence level on the use of PHQ-9 depression screening tool. The results of the
pre/posttest were presented to the clinical team. The outcomes from the project will be
disseminated to another clinic.
Protection of Human Subjects
The project was on staff education: no patient intervention was included.
Participant’s confidentiality and privacy was maintained throughout the project.
Permission from the IRB at Walden University was granted and assigned approval
number is 09-18-19-0409447. Providers participation was voluntary, and the participants
were able to withdraw from the program at any time. All the data was deidentified and
remains anonymous, and the participant questionnaires will be stored securely at the
clinic for five years. The computer used by the DNP student was password protected.
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Prior to their participation, each of the participants gave their consent to complete an
anonymous questionnaire. A site agreement form was signed, and Walden IRB approval
was obtained. The project implementation site did not require IRB approval. The clinic
deferred to the university and accepted their IRB approval process. Outliers and missing
information were unremarkable due to the small number of participants.
Analysis and Synthesis
The main goal for the DNP project was to develop, deliver, and evaluate an
educational program for care providers regarding use of the PHQ-9 screening tool for the
identification of depression in an outpatient clinic setting. The approach used was a
quantitative method to analyze the data and present the results. The pretest/posttest was
used to measure the outcome of the education and the data was analyzed using SPSS 26.0
(2017) software. A descriptive analysis was used to report the results, while the
utilization of the t-test was used for the analysis because the same subjects were being
tested in different times (pre/posttest). The t-test is appropriate when we are trying to
determine if the means of the 2 variables (pre/posttest) are statistically different or
significant. The level of significant (p) is set at 0.5. The project did not have any control
or experimental groups.
Summary
Providers have a vital role to play with regards to diagnosing and managing
depression in an outpatient clinic. This section of the project discussed the doctoral
proposal plan for collecting and analyzing the evidence with a well-defined source of the
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evidence, description of how the data was collected, measured, and the ethical protection
of the participants.
In the next Section, a report on the statistical findings and implications that
resulted from the analysis will be completed. Discussions of any unforeseen limitations
or outcomes and their potential impact on the findings will be evaluated. The implications
resulting from the findings and potential implications to social change will be discussed.
Recommendations that will potentially address the gap-in-practice as indicated by the
findings will be highlighted.
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Section 4: Findings and Recommendations
Introduction
The problem addressed in this project results from the lack of knowledge and selfconfidence on the use of PHQ-9 screening tool to diagnose and manage depression by
providers at an outpatient clinic. The DNP project answers the project-focused question:
PFQ: In providers managing depression in an outpatient psychiatric clinic, does
education on using the PHQ-9 tool increase staff knowledge and confidence in a
1-month period?
The purpose of the DNP project was to develop, deliver, and evaluate an educational
intervention that addresses the management of depression using the PHQ-9 screening tool
as an instrument to identify patients suffering from depression.
The USPSTF (2016) recommended screening for depression irrespective of the
risk factors. It was noted that at this local facility, the required standard for depression
screening using the PHQ-9 tool was not met. They reported a 50% usage, which was
below the national average of 60% and below the recommended standard for screening
patients using PHQ-9 tool, which is 100% for all providers (USPSTF, 2016). This
identified gap in practice created the purpose of the project, which was to educate
providers and build their confidence in using the PHQ-9 screening tool in managing
patients with depression.
The validation for this project was obtained from two sources: the clinic and
scholarly databases. The scholarly databases included Medline, CINAHL, EBSCO host,
Ovid Plus, Walden University library, Google Scholar, and Pub Med. I performed a
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search related to the project topic and reviewed current literature. I examined a total of
750 articles. The search was limited to studies published in English from 2010 to 2018.
The number was reduced to 60 articles with 10 selected as relevant to the clinical setting
and depression management.
Analytical strategies used for the staff development project were the Iowa EBP
model and pretest and posttest evaluations before and after a PowerPoint educational
program. For the project I used a quantitative method to analyze the data and present the
results. I analyzed the pretest/posttest to measure of the outcome of the educational
intervention using SPSS 26.0 software. I provided a descriptive analysis along with the
quantitative method, including the use of the paired t test. The paired t test was used for
the analysis because the same subjects were being tested in different times
(pretest/posttest). The t test was used to determine if the means of the 2 variables
(pretest/posttest) were statistically different or significant. The level of significant (p) was
set at 0.5.
Findings and Implications
The clinical team collected and provided data from their quality report indicating
a gap in practice in this clinic. A pretest questionnaire was used for this project to assess
the providers’ knowledge and confidence levels in using PHQ-9 tool to diagnose and
manage client depression. Providers were educated on the use of PHQ-9 depression
screening tool to manage depression during a 45-minute PowerPoint presentation. A
posttest was given to evaluate their knowledge and confidence levels immediately after
education and again 1 month after the education. The outcome was measured using a
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pretest and posttest analysis. A total of six providers in the clinic participated in the
educational program. All six providers completed the pretests and post-tests. The staff
educational program was developed to enhance provider knowledge and confidence
levels on the use of PHQ-9 tool in diagnosing and managing depression. All six
participants completed the consent form prior to the presentation of the educational
program. The documents created were as follows: (a) Iowa Model of EBP (see Appendix
A), (b) PHQ-9 ( See Appendix B), (c) Depression Toolkit (see Appendix C), (d)
Knowledge/Confidence Level Questionnaire (see Appendix D), (e) Acknowledgement of
Receipt and Review of PowerPoint Presentation( see Appendix E), (f) an educational
curriculum plan (see Appendix F). The clinic had no routine depression screening
practices in place at baseline. The results of the tests show a statistically significant
difference between pretest score and posttest score on knowledge of PHQ-9.
Evaluation of the Participants Knowledge
In order to evaluate participants’ knowledge, I analyzed the results of the pretest
and the posttest (see Table 1 and Figure 1)
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Table 1
Pretest Posttest Knowledge of Using the PhQ-9 Screening Tool in Depression
Management
Participant

Pretest

Posttest
immediately
after
intervention

Posttest 1
month after
intervention

P1

8

20

20

P2

10

19

20

P3

12

16

20

P4

4

19

19

P5

17

20

20

P6

8

19

20

M

9.83

18.83

19.83

Figure 1. Histogram of data representing knowledge scores.

38
In order to assess the effectiveness of the educational intervention of the
PowerPoint presentation on the use of PHQ-9 depression screening tool, a mean score of
the participants were recorded before (µ = 9.8333) and after (µ = 18.8333) the
intervention. The percentage change in the pretest/posttest scores were also computed
using the formula [ change in % = (new mean - old mean) ÷ old mean × 100]. There was
an average increase of 9 in the mean scores of the participants and a 92 % increase of
knowledge from pretest to posttest. In order to evaluate if the change in the mean was
statistically significant, the p-value was computed using the paired t test. The result (p =
.005) was found to be statistically significant with α set at .05. Since p < α, this indicated
that the intervention was successful. After 1 month, it was noted that an increase in the
difference of the mean from 9 to 10 with a p value of .002 occurred, indicating further
improvement in the average Likert scale score of the participants knowledge.
Evaluation of the Participants Confidence Level
In order to evaluate participants knowledge, the results of the pretest and the
posttest were analyzed looking specifically at differences in confidence levels of the
participants (see Table 2 and Figure 2).
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Table 2
Pretest/Posttest on Confidence Level of using the PHQ-9 Screening Tool in Depression
Management
Participants

Pretest

Posttest
Immediately After
Intervention

Posttest 1 month
After Intervention

P1

8

18

20

P2

15

19

20

P3

12

16

20

P4

4

18

19

P5

20

20

20

P6

8

20

20

M

11.17

16.53

19.83

Figure 2. Histogram of data representing confidence scores.
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In order to assess the effectiveness of the educational intervention on the
confidence level, the mean score of the participants was recorded before (µ = 11.1667)
and after (µ = 18.500) the intervention. The percentage change in the pretest/posttest
scores were also computed using the formula [ change in % = (new mean - old mean) ÷
old mean × 100]. There was an average increase of 7.3 in the mean scores of the
participants and a 65 % increase of knowledge from pretest to posttest. In order to
evaluate if the change in the mean was statistically significant, the p-value was computed
using the paired t test. The result (p = .022) was found to be statistically significant with α
set at .05. Because p < α, this indicates that the intervention was successful in increasing
providers’ confidence levels.
After 1 month, it was noted that an increase in the difference of the mean from 7.3
to 8.6 with a p-value of .012 indicated further improvement in the average Likert scale
score of the participants confidence level. The education module showed significant
improvement in the providers’ knowledge on using PHQ-9 tool for diagnosing and
managing depression. Following the educational presentation, a hard copy of the
educational module was presented to the clinical team (Appendix F).
Educating providers increased their knowledge and confidence level on how to
successfully administer PHQ-9 screening tool, which significantly increased the use of
best practices. The primary outcome of this project was increased provider knowledge,
confidence, and assessment skills when identifying signs and symptoms of depression in
the clinical setting.
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Project Implications
This evidence-based educational program has the potential to improve knowledge
and enhance confidence level while also integrating EBP knowledge in screening for
depression using the PHQ-9 tool by providers by in the outpatient clinic. With all the
positive feedback from the clinical team, along with the statistically significant results,
this evidence-based project contributes to practice excellence and quality patient
outcomes. According to Williams et al. (2017), depression is identified as a contributing
factor to increased disability globally, which is costing the United states in 2016
approximately $233 billion dollars. This educational project will positively influence
social change by reducing the incidence of undiagnosed and untreated depression among
patients who are seen by providers at the clinic thereby reducing the financial issues
caused by depression on the economy (Williams, Chung, & Muennig, 2017). The
ongoing promotion of depression screening would provide a social shift among the
providers at the clinic by using the PHQ-9 depression screening tool to give the
opportunity for best possible diagnosis and treatment of depression, which also will
promote the health and wellness of clients, families, and the community.
Recommendations
This DNP project suggests that implementing an educational intervention on the
use of the PHQ-9 depression screening tool is, not only beneficial to the providers, but
also to the clinic as new hires will have the opportunity to benefit from the PowerPoint
presentation. It should be noted that this project did not evaluate patient’s outcome as a
result of the intervention. However, it evaluated providers’ knowledge and their
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confidence in utilizing the PHQ-9 depression screening tool. This should assist in
maintaining the sustainability of the use of PHQ-9 tool by providers. It is realistic to
recommend that all new providers hired at the clinic receive this education to improve
their knowledge and enhance their confidence level on the utilization of the PHQ-9
depression screenings tool. Another recommendation would be incorporating a teaching
PHQ-9 tool to new providers orientation package. This was an educational project that
will continue to move forward long after the completion of this project and will better
serve the needs of the patient population and the providers.
In reviewing the responses from the questionnaire, several recommendations were
made for future projects to address the gaps in practice. The time limitations and the
inconsistent demands in the clinic are challenges to effectively screening patients for
depression using PHQ-9 tool. Thus, an important recommendation was to create a
standard documentation process for providers using the PHQ-9 tool for every patient who
comes to the clinic. Another recommendation would be for the clinic to study patient
outcomes as they relate to the increase usage of the PHQ-9 to determine whether
consistent usage results in the correct diagnosis and treatment of these patients.
This evidence-based educational program has the potential to improve knowledge
and enhance confidence level while integrating evidence-based knowledge into practice.
This project will influence positive social change by reducing the incidence of
undiagnosed and untreated depressive patients who are seen at the clinic. It is
recommended that the project be standardized for use at similar outpatient facilities
which has many patients with the potential diagnosis of depression. The more patients are
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diagnosed and treated for depression withing a community, the more positive outcomes
for the patient, family, and the community. This could help reduce the financial
constraints caused by depression on the economy (Williams, Chung, & Muennig, 2017).
Another recommendation would be that the project be implemented over a longer period
to verify the results of this project. Finally, looking at patient outcomes as a result of
correctly diagnosing depression early in their treatment would be necessary to validate
the usefulness of consistent usage of the PHQ-9.
Contributions of the Project Team
The Project Team
The project team consisted of clinical team members who are experts in this field.
The team members were very involved in the development of the project as they
contributed in the identification of the gap in practice, reviewed and evaluated the content
of the educational module to determine accuracy, corroborated on the instrument used for
data collection and confirmed the pretest and posttest results. Some of the revisions made
to the content of the educational module was based on the feedback provided by the
clinical team also called the “Project Team”. The clinical team supported the
development and implementation of the educational program to attain the goal of the
project.
The Doctor of Nursing Practice Student
The DNP student took the leadership role in the project. The student collected the
pre/posttest data, presented the PowerPoint educational material, and analyzed the data.
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Both the DNP student and the project team members suggested the proposed
recommendations.
Strengths and Limitations of the Project
The strength of the project is that it met the gap in practice for this outpatient
clinic and targeted the problem the clinic was facing. Another strength was the
collaboration the clinic gave this DNP student, as a shared goal was the overarching
concern. The motivation of this learner to truly make a difference in the lives of patients
suffering from depression was another strength of the project.
Limitations included the fact that the number of participants was small so the
result cannot be generalized. Demographically, all the participants were female, which
could impact the way questions were answered on the pre-and-posttest surveys. All the
participants were selected from one facility, which limits perceptual diversity in their
responses to the questionnaire. It was difficult to have all the participants in one session
for the PowerPoint presentation resulting in some participants reviewing the presentation
without the opportunity to ask questions. Another limitation of this project was the
amount of time used to collect data. The four weeks for data collection may not have
been enough time to ensure consistency of using the PHQ-9 depression screening tool in
managing patients with depressions.
Summary
This section of the project highlighted the findings and implication of the project.
It presented the results and discussed the limitations and recommendations of the project.
The role of the project team was also reviewed. Section Five will focus on plans for
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disseminating the findings and recommendation to the facility and a wider audience in
nursing. The analysis of self and the role as a practitioner, project manager, scholar will
also be discussed including challenges and insight gained during this project.
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Section 5: Dissemination Plan
Dissemination
Dissemination is an important part of any DNP project because it ensures the
research has a social, political, or economical influence on people. Dissemination brings
to the attention of stakeholders of research’s outcomes and conclusions, which enhances
knowledge regarding the implementation of the research (Marín-González, Malmusi,
Camprubí, & Borrell, 2017). The plan is to educate providers on the use of PHQ-9
screening in outpatient clinics within my geographical area in the promotion of better
patient outcomes for depressed patients. I also intend to present my project at a nursing
conference and may consider publishing my project findings.
Analysis of Self
This DNP project helped developed my self-confidence in project implementation
and evaluation. Furthermore, I found my ability to function in a leadership role in
developing, improving, and decision-making process has grown. The project
implementation improved my collaborative skills in working with the clinical team, as we
sought to integrate evidence-based changes in an evolving healthcare system. Upon
completion of this scholarly journey, I was able to gain confidence in speaking in public
to an audience of peers. I learned to trust myself as a scholar and leader who has a
knowledge set that I could share with other professionals. One of my long-term goals is
to work in a nongovernmental organization located in a rural area where the
implementation of health care projects in mental health is desperately needed.
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Summary
The number of patients diagnosed with depression increases by about 20% each
year. Depression often goes undiagnosed and without treatment. The United States
reported there is an estimate two- thirds of undiagnosed depression cases, leading to
untreated depression (Williams et al., 2017). If depression is left untreated, it can cause
disabling symptoms that can negatively affect the quality of life. Recently, there has been
an initiative in the United States to identify and treat depression (Sparer, Muennig, &
Brown, 2016). This project addressed the lack of routine depression screening by
providers to identify those at risk or needing treatment. The results from this DNP project
support education on the use of the PHQ-9 depression screening tool to enhance
participants’ knowledge and their confidence levels.

48
References
Abar, B., Hong, S., Aaserude, E., Holub, A., & DeRienzo, V. (2017). Access to care and
depression among emergency department patients. The Journal of Emergency
Medicine, 53(1), 30–37.
American Association of Colleges of Nursing. (2006). The essential of doctoral
education for advancing nursing practice. Retrieved from
http://www.aacn.nche.edu/publications/position/DNP Essentils.pdf
Ahrnsbrak, R., Bose, J., Hedden, S., Lipari, R., & Park-Lee, E. (2016). Key substance use
and mental health indicators in the United States: Results from the 2016 National
Survey on Drug Use and Health. Retrieved from
https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2016/NSDUHFFR1-2016.htm
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental
disorders (5th ed.). Washington, D.C: Author. Retrieved from
http://dsm.psychiatryonline.org.jproxy.lib.ecu.edu/
American Psychological Association. (2015). Depression. Apa.org. Retrieved from:
http://www.apa.org/topics/depress/
American Psychological Association. (2016). Patient health questionnaire. Retrieved
from:
http://www.apa.org/pi/about/publications/caregivers/practicesettings/assessment/t
ools/patient-health.aspx
Arroll, B., Goodyear-Smith, F., Crengle, S., Gunn, J., Kerse, N., Fishman, T., . . .

49
Hatcher, S. (2010). Validation of PHQ-2 and PHQ-9 to screen for major
depression in the primary care population. Annals of Family Medicine, 8(4), 348353. doi:10.1370/afm.1139
Beard, C., Rifkin, L. S., & Björgvinsson, T. (2017). Characteristics of interpretation bias
and relationship with suicidality in a psychiatric hospital sample. Journal of
Affective Disorders, 207, 321–326. doi:10.1016/j.jad.2016.09.021
Bess, K. D., Adams, J., Watt, M. H., Odonnell, J. K., Gayes, B. N., Thielman, N. M., . . .
Pence, B. W. (2013). Providers’ attitudes towards treating depression and selfreported depression treatment practices in HIV outpatient care. AIDS Patient Care
and STDs, 27(3), 171–180. doi:10.1089/apc.2012.0406
Boaz, A., Hanney, S., Borst, R., O'Shea, A., & Kok, M. (2018). How to engage
stakeholders in research: design principles to support improvement. Health
Research Policy and Systems, 16(1), 60. doi:10.1186/s12961-018-0337-6
Brody, D., Pratt, L., & Hughes, J. (2018). Prevalence of depression among adults aged 20
and over: United States, 2013–2016. NCHS Data Brief, 303, 1–8. Retrieved from
https://europepmc.org/abstract/med/29638213
Brown, C. G. (2014). The Iowa model of evidence-based practice to promote quality
care: An illustrated example in oncology nursing. Clinical Journal of Oncology
Nursing, 18(2), 157–159. doi:10.1188/14.CJON.157-159
Buckwalter, K. C., Cullen, L., Hanrahan, K., Kleiber, C., McCarthy, A. M., Rakel, B., &
Tucker, S. (2017). Iowa model of evidence-based practice: Revisions and
validation. Worldviews on Evidence-Based Nursing, 14(3), 175–182.

50
doi:10.1111/wvn.12223
Centers for Disease Control and Prevention. (2013). Workplace health promotion:
Depression. Retrieved from
http://www.cdc.gov/workplacehealthpromotion/implementation/topics/depression
.html
Culpepper, L., Muskin, P. R., & Stahl, S. M. (2015). Major depressive disorder:
Understanding the significance of residual symptoms and balancing efficacy with
tolerability. American Journal of Medicine, 128, 1–15.
doi:10.1016/j.amjmed.2015.07.001
DeCapua. M. (2018). The latest depression screening recommendations. Retrieved from
https://www.healthecareers.com/article/must-read-for-all-nurse-practitioners.
Dentje, K. (2015). Evidence-based practice: Understanding the process. Advanced
Practice Nursing, 7(4), 1–3. Retrieved from
http://www.medscape.com/viewaIrticle/567786_4
De Winter, J.C.F. (2013) "Using the Student's t-test with extremely small sample sizes,"
Practical Assessment, Research, and Evaluation, 18, Article 10.
Diagnosis. (2018). Stedman’s medical dictionary. Retrieved from
http://www.medilexicon.com/dictionary/24385
Doody, C. M., & Doody, O. (2014). Introducing evidence into nursing practice: Using the
Iowa model. British Journal of Nursing, 20(11), 661–664.
doi:10.12968/bjon.2011.2011.66.
Funderburk, J. S., Crasta, D., & Maisto, S. A. (2016). Training and administration of

51
behavioral health screens in the Veterans Health Administration. Quality in
Primary Care, 24(3), 98-105.
Gay, C. L., Kottorp, A., Lerdal, A., & Lee, K. (2016). Psychometric limitations of the
center for epidemiologic studies-depression scale for assessing depressive
symptoms among adults with HIV/AIDS: A Rasch analysis. Depressive Research
and Treatment, 1-11. doi:10.1155/2016/2824595
Greenberg, P. E., Fournier, A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015). The
economic burden of adults with major depressive disorder in the United States
(2005 and 2010). Journal of Clinical Psychiatry, 76(2), 155–U115.
doi:10.4088/JCP.14m09298
Grove, S., Burns, N., & Gray, J. (2013). The practice of nursing research: Appraisal,
synthesis and generation of evidence (7th ed.). St. Louis, MO: Saunders Elsevier.
Haefner, J., Daly, M., & Russell, S. (2017). Assessing depression in primary care. Journal
of Doctoral Nursing Practice, 1 O(I), 1 - I I.
Hamid, G. M., & MacKenzie, M. A. (2017). CE. AJN, American Journal of Nursing,
117(7), 32-40. doi:10.1097/01.naj.0000520919.26724.9b
Hayden, J. (2019). Introduction to health behavior theory. Burlington, MA: Jones &
Barlett Learning.
Health Resource and Services Administration. (2015). Clinical care guidelines and
resources. Retrieved from
https://hab.hrsa.gov/deliverhivaidscare/clinicalguidelines.html
Hofmann, S. G., Curtiss, J., Carpenter, J. K., & Kind, S. (2017). Effect of treatments for

52
depression on quality of life: A meta-analysis. Cognitive Behavior Therapy,
46(4), 265–286.
Horton, M., & Perry, A. E. (2016). Screening for depression in primary care: A Rasch
analysis of the PHQ-9. BJPsych Bulletin, 40(5), 237–243.
doi:10.1192/pb.bp.114.050294
Kroenke, K., Spitzer, R.L., & Williams, J.W. (2001). The PHQ-9: Validity of a brief
depression severity measure. Journal of General Internal Medicine, 16(9), 606613. doi:10.1046/j.1525-1497.2001. 016009606.x
Kroenke, K., Spitzer R. L., Williams, J. B., & Löwe, B. (2010). The Patient Health
Questionnaire somatic, anxiety, and depressive symptom scales: A systematic
review. General Hospital Psychiatry, 32(4), 345–359.
doi:10.1016/j.genhosppsych.2010.03.006
Ledford, H. (2014). Medical research: If depression were cancer. Nature, 515(7526),
182–184. doi:10.1038/515182a
Manea, L., Gilbody, S., & McMillan, D. (2012). Optimal cut-off score for diagnosing
depression with the patient health questionnaire (PHQ-9): A meta-analysis.
CMAJ, 184(3), E191–E196. doi:10.1503/cmaj.110829
Marín-González, E., Malmusi, D., Camprubí, L., & Borrell, C. (2017). The role of
dissemination as a fundamental part of a research project. International Journal of
Health Services, 47(2), 258–276. doi:10.1177/0020731416676227
Maurer, D. M., & Darnall, C. (2012). Screening for depression. American Family
Physician, 15(2), 139-144. Retrieved from hptt://www.aafp.org/afp

53
McLeod, S. A. (2019, Aug 03). Likert scale. Simply Psychology.
https://www.simplypsychology.org/likert-scale.html
Mitchell, A., Yadegarfer, M., Gill, J., & Stubbs, B. (2016). Case finding and screening
clinical utility of the Patient health Questionnaire (PHQ-9 and PHQ-2) for
depression in primary care: A diagnostic meta-analysis of 40 studies. BJ Psych
Open, 2, 127-138. doi:10.1192/bjpo.bp.115.001685.
Morin, A. (2018). How many people are affected by depression every year? Retrieved
from the very well mind website: https://www.verywellmind.com/depressionstatistics-everyone-should know--4159056
National Alliance on Mental Illness. (2019). Mental health by the numbers. Retrieved
from https://www.nami.org/Learn-More/Mental-Health-By-the-Numbers
National Institute of Mental Health. (2015). What is Depression? Retrieved from
http://www.nimh.nih.gov
National Alliance on Mental Illness. (2015). Depression. Retrieved from
http://www.nami.org/learn-more/mental-conditions/depression
National Institute of Mental Health. (2016). Depression. Retrieved from
https://www.nimh.nih.gov/health/topics/depression/index.shtml
National Institute of Mental Health. (2017). Major Depression. National Institute of
Health: United States Department of Health and Human Services. Retrieved from:
https://www.nimh.nih.gov/health/statistics/major-depression.shtml
National Institute of Mental Health. (2019). Major depression. Retrieved from
https://www.nimh.nih.gov/health/statistics/major-depression.shtml

54
Peters, M. A. (2018). Identifying depression in primary care: An evidence-based
intervention (Doctoral study, The University of Toledo and Wright State
University).
Picardi, A., Lea, I., Tarsitani, L., Caredda, M., Matteucci, G., Zerella, M., . . . The
SETDEP Group. (2016). A randomized controlled trial of the effectiveness of a
program for early detection and treatment of depression in primary care. Journal
of Affective Disorders, 198, 96-101. doi:10.1016/j.jad.2016.03.025
Porter, C. (2017). The silent illness: The importance of screening for depression in
primary care. Retrieved: from https://genesight.com/the-silent-illnesstheimportance-of-screening-for-depression-in-primary-care/
Primeau, M. M., Avellaneda, V., Musselman, D., St. Jean, G., & Illa, L. (2013).
Treatment of depression in individuals living with HIV/AIDS. Psychosomatics,
54(4), 336–344. doi:10.1016/j.psym.2012.12.001
Screening. (2018). In Stedman’s medical dictionary. Retrieved from
http://www.medilexicon.com/dictionary/80398
Seo, J. G., & Park, S. P. (2015). Validation of the Patient Health Questionnaire-9 (PHQ9)
and PHQ-2 in patients with migraine. Journal of Headache and Pain, 16, 65.
doi:10.1186/s10194-015-0552-2
Sparer M., Brown L., Muennig P. (2016). (Re) Defining the health care delivery system:
The role of social services. (KPMG White Paper, Draft Copy. For release June
2016.).
Siu, A. L. (2016). Screening for depression in adults: U.S. Preventive Services Task

55
Force recommendation statement. JAMA, 315(4), 380–387.
doi:10.1001/jama.2015.18392
Smithson, S., & Pignone, M. P. (2017). Screening adults for depression in primary care.
Medical Clinics of North America, 101(4), 807–821.
doi:10.1016/j.mcna.2017.03.010
Social change. (2018). In Stedman’s medical dictionary. Retrieved
fromhttp://www.medilexicon.com/dictionary/
Stedman’s Medical Dictionary. (2018). Depression. Retrieved from
http://www.medilexicon.com/dictionary/23823
Thombs, B. D., Benedetti, A., Kloda, L. A., Levis, B., Nicolau, I., Cuijpers, P., . . .
Ziegelstein, R. C. (2014). The diagnostic accuracy of the Patient Health
Questionnaire-2 (PHQ-2), Patient Health Questionnaire-8 (PHQ-8), and Patient
Health Questionnaire-9 (PHQ-9) for detecting major depression: Protocol for a
systematic review and individual patient data meta-analyses. Systematic Reviews,
3, 124. doi:10.1186/2046-4053-3-124
U.S. Department of Health, Education, and Welfare. (2017). The Belmont Report: Ethical
principles and guidelines for the protection of human subjects of research.
Washington, DC: Author. Retrieved from
https://www.hhs.gov/ohrp/sites/default/files/the-belmont-report-508c_FINAL.pdf
(Original work published in 1979)
U.S. Preventive Services Task Force. (2015). Final update summary: Depression in
adults: Screening. Retrieved from

56
http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFi
nal/depression-in-adults-screening
U.S. Preventive Services Task Force. (2016). Screening for depression in adults: U.S.
Preventive Services Task Force recommendation statement. JAMA, 315(4), 380–
387.
Williams, S. Z., Chung, G. S., & Muennig, P. A. (2017). Undiagnosed depression: A
community diagnosis. Social Science and Medicine Journal. 3, 633–638.
World Health Organization. (2013). Mental health action plan, 2013–2020. Retrieved
from http://apps.who.int/iris/bitstream/10665/89966/1/9789241506021_eng.pdf?u
World Health Organization. (2014). Global health estimates: 2014 summary tables.
Retrieved from
http://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html
World Health Organization. (2015a). Depression. Retrieved from
http://www.who.int/mediacente/factsheets
World Health Organization. (2015b). Depression fact sheet. Retrieved from
http://www.who.int.ezproxy.gvsu.edu/mediacentre/factsheets/fs369/en/
World Health Organization. (2018). Depression. Retrieved from:
http://www.who.int/mediacentre/factsheets/fs369/en/.

57
Appendix A: Iowa Model of Evidence-Based Practice

Note. From “Introducing Evidence into Nursing Practice: Using the Iowa Model,” by C.
Doody & O. Doody, 2011, British Journal of Nursing, 20, p. 661-4. Retrieved from:
https://www.researchgate.net/publication/51466031_Introducing_evidence_into_nursing_
practice_Using_the_IOWA_model
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Appendix B: Patient Health Questionnaire-9

PATIENT HEALTH QUESTIONNAIRE-9
(PHQ-9)
Over the last 2 weeks, how often have you been
bothered by any of the following problems? (Use “✔” to
indicate your answer)

Not at all

Several
days

More
than half
the days

Nearly
every
day

1. Little interest or pleasure in doing things

0

1

2

3

2. Feeling down, depressed, or hopeless

0

1

2

3

3. Trouble falling or staying asleep, or sleeping too much

0

1

2

3

4. Feeling tired or having little energy

0

1

2

3

5. Poor appetite or overeating

0

1

2

3

6. Feeling bad about yourself — or that you are a failure or
have let yourself or your family down

0

1

2

3

7. Trouble concentrating on things, such as reading the
newspaper or watching television

0

1

2

3

0

1

2

3

0

1

2

3

8. Moving or speaking so slowly that other people could
have noticed? Or the opposite — being so fidgety or
restless that you have been moving around a lot more than
usual
9. Thoughts that you would be better off dead or of hurting
yourself in some way

FOR OFFICE CODING

0

+ ______ + ______ + ______
=Total Score: ______

If you checked off any problems, how difficult have these problems made it for you to do your work,
take care of things at home, or get along with other people?
Not difficult at
Somewhat difficult
Very difficult
Extremely
all
difficult





Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an educational grant from
Pfizer Inc. No permission required to reproduce, translate, display or distribute.
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Appendix C: Depression Toolkit Contents Guidelines for using PHQ-9
PHQ-9 Depression Severity Score Proposed Treatment Actions
0 – 4 Minimal
No treatment recommended.

5 – 9 Mild depression
Watch the patient closely just in case it progresses. No treatment recommended

10 – 14 Moderate depression
Propose treatment and counseling.

15 – 19 Moderately severe depression
Patient needs active treatment: pharmacotherapy and psychotherapy.

20 – 27 Severe depression
Patient requires immediate initiation of treatment; expedite referral to a mental health
specialist.

Note. From “Attitudes Toward Dissertation Editors,” by W. Student, 2008, Journal of
Academic Optimism, 98, p. 11. Reprinted with permission. [if needed?] from New York
State Department of Health (2016).
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Appendix D: Knowledge/Confidence Level Pre-/Posttest Questionnaire

The purpose of this questionnaire is to assess provider’s knowledge/confidence level in
the utilization of the PHQ-9 screen tool for Depression management. Please respond to
questions 1-10 with the most appropriate answer
1.Please indicate your age. 20-29 [], 30-39 [], 40-49 [], 50-59 [], over 60 []
2.What is your gender? Female [], Male []
3.What educational degree do you hold; NP □, MD □, PMHNP □, FNP □
In items 4 - 13 below, please respond with your appropriate level of agreement:
1 = Strongly Disagree (SD), 2= Disagree (D), 3= Neutral (N), 4= Agree (A), 5= Strongly Agree
(SA).

SD D N A SA
1
4. I have adequate knowledge in using the PHQ -9 for
depression screening
5. I have adequate knowledge in using the PHQ -9 for
depression diagnosis
6. I have adequate knowledge in using the PHQ-9 for
monitoring depression management
7. I have adequate knowledge in using the PHQ -9 tool for
measuring severity of depression
8. I have the desire to receive further education that will
improve my knowledge in utilizing the PHQ-9 tool

2

3

4

5

61
9. I am confident in my ability to use the PHQ-9 tool for
depression screening
10.I am confident in my ability to use the PHQ-9 tool for
diagnosing depression
11.I am confident in my ability to use the PHQ-9 tool for
monitoring the progression of depression management
12.I am confident in my ability to use the PHQ-9 tool for
measuring the severity of depression s
13.I have the desire to receive further education that will
improve my knowledge in utilizing the PHQ-9 tool
Total Score
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Appendix E: Acknowledgement of Receipt and Review of PowerPoint Presentation on
Staff Education: Depression Screening in an Outpatient Setting

Participants
(Nurses)

P1
P2
P3
P4
P5
P6

Signature

Date
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Appendix F: Educational Curriculum Program
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